This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Tonix Medicines, Inc., Upsher Smith Laboratories, Inc.. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2026
Title: The Innovative Mind of Piyush Gupta
Introduction
Piyush Gupta, an inventor based in Ghaziabad, India, has made significant contributions to the field of pharmaceuticals, particularly in the treatment of migraines. With three patents to his name, Gupta's work demonstrates his commitment to developing effective solutions for patients suffering from this debilitating condition.
Latest Patents
Gupta's latest inventions revolve around pharmaceutical compositions designed to treat migraines. One notable patent outlines a method for treating migraine or cluster headache in human patients by administering a subcutaneous composition comprising sumatriptan or its pharmaceutically acceptable salt. This method involves delivering an amount equivalent to 3 mg of sumatriptan base, showcasing Gupta's innovative approach to migraine treatment.
Career Highlights
Throughout his career, Piyush Gupta has worked with reputable organizations, including Upsher Smith Laboratories, Inc. and Tonix Medicines, Inc. His experiences in these companies have undoubtedly enriched his expertise and fueled his drive to create impactful pharmaceutical solutions.
Collaborations
Gupta's journey has also included collaborations with talented professionals in the field, such as Prabhu Prabhakara and Rajesh Ramesh Patil. Working alongside these individuals has likely fostered an environment of shared ideas and innovation, further enhancing Gupta's contributions to pharmaceuticals.
Conclusion
With a focus on developing effective treatments for migraines, Piyush Gupta stands out as an accomplished inventor in the pharmaceutical industry. His dedication to innovation and collaboration has led to meaningful advancements, benefiting countless patients in need of relief from migraine symptoms.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
